Author Archives: clientekdev

https://futurism.com/researchers-provide-the-first-evidence-that-a-new-kind-of-paralysis-treatment-is-effective/ A new study has revealed the potential for cortical targets to improve motor function in those struggling with paralysis. Cortical targets are relatively unexplored territory for treatment, so building off this research could lead to even more exciting discoveries.

http://www.prnewswire.com/news-releases/patients-with-complete-paralysis-show-additional-recovery-of-arm-hand-and-finger-function-at-9-months-after-treatment-with-asterias-ast-opc1-300472759.html FREMONT, Calif., June 13, 2017 /PRNewswire/ — Asterias Biotherapeutics, Inc. (NYSE MKT: AST), a biotechnology company pioneering the field of regenerative medicine, today announced that new 9-month follow-up data from the AIS-A 10 million cell cohort in the company’s ongoing SCiStar Phase 1/2a clinical trial shows three of six (50%) patients..

https://www.ptcommunity.com/wire/neuralstem-expands-phase-1-safety-trial-nsi-566-neural-stem-cells-spinal-injury GERMANTOWN, Md., April 12, 2017 (GLOBE NEWSWIRE) — Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company focused on the development of nervous system therapies based on its neural stem cell technology, announced that a new cohort of four patients will be added to its ongoing Phase 1 human clinical trial evaluating the safety and feasibility ofContinue reading “Neuralstem Expands Phase 1 Safety Trial of NSI-566 Neural Stem Cells in Spinal Injury”

http://www.businesswire.com/news/home/20170323005389/en/InVivo-Initiate-Cervical-Spinal-Cord-Injury-Study – Company Receives Investigational Testing Authorization from Health Canada to Conduct Cervical Spinal Cord Injury Study – March 23, 2017 08:00 AM Eastern Daylight Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (NVIV) today announced that Health Canada has approved the company’s Investigational Testing Authorization application to commence a clinical study of the Neuro-Spinal Scaffold™Continue reading “InVivo to Initiate Cervical Spinal Cord Injury Study”

https://www.uq.edu.au/news/article/2017/01/new-trial-may-revolutionise-treatment-of-spinal-cord-injury-patients Queensland researchers are launching a world-first clinical trial aimed at improving recovery from spinal cord injuries. In the study, led by The University of Queensland and The Princess Alexandra (PA) Hospital, a new anti-inflammatory drug will be given to participants within hours of spinal trauma in an effort to minimise tissue damage…

http://www.cnn.com/2016/11/09/health/paralyzed-monkeys-walking-brain-implant/ By Meera Senthilingam, CNN A new form of brain implant could one day help people with paraplegia regain control of their legs, based on a new study proving its potential in paralyzed monkeys. Researchers at the École polytechnique fédérale de Lausanne (EPFL) in Switzerland were able to restore…

http://www.courier-journal.com/story/life/wellness/health/2016/10/24/uofl-wins-5-million-help-spinal-patients/92667274/ Researchers at the University of Louisville and Columbia University have been awarded a $5 million grant to develop a robotic device to help spinal cord injury patients get their balance back…

https://www.sciencedaily.com/releases/2016/10/161012102702.htm Researchers successfully boosted the regeneration of mature nerve cells in the spinal cords of adult mammals — an achievement that could one day translate into improved therapies for patients with spinal cord injuries…

https://www.sciencedaily.com/releases/2016/09/160914095610.htm Physicians at Rush University Medical Center became the first in Illinois to inject AST-OPC1 (oligodendrocyte progenitor cells), an experimental treatment, into the damaged cervical spine of a recently paralyzed man as part of a multicenter clinical trial. Dr. Richard G. Fessler, professor of neurological surgery at Rush University …

http://www.massdevice.com/invivo-therapeutics-touts-case-study-1st-spine-scaffold-implant/ InVivo TherapeuticsInVivo Therapeutics (NSDQ:NVIV) this week touted a case study of the 1st implantation of its spinal scaffold, a bioresorbable device designed to help treat traumatic spinal cord injuries. The study, published in Neurosurgery, the journal of the Congress of Neurological Surgeon…

http://www.massdevice.com/fourth-patient-converts-complete-incomplete-spinal-cord-injury-invivo-trial/ FINK DENSFORD InVivo TherapeuticsInVivo Therapeutics (NSDQ:NVIV) said today 4th patient in the Inspire study of its Neuro-Spinal Scaffold has improved from a complete AIS A spinal cord injury to an incomplete AIS B spinal cord injury. The Cambridge, Mass.-based company’s neuro-spinal scaffold is surgically implanted following acute spinal cord injuries to act as aContinue reading “Fourth patient converts from complete to incomplete spinal cord injury in InVivo trial”

http://www.latimes.com/science/sciencenow/la-sci-sn-spinal-cord-hand-movement-20160413-story.html Melissa Healy After a broken neck left him a quadriplegic, Ian Burkhart was told he would never be able to use his hands. Now he can grasp a bottle and pick up a credit card by using a computer plugged directly into his brain and special software that decodes his thoughts and converts themContinue reading “Leaping over spinal cord injury, researchers teach a quadriplegic’s hand to move again”

http://globenewswire.com/news-release/2015/11/19/788698/0/en/Athersys-MultiStem-Promotes-Recovery-After-Acute-Spinal-Cord-Injury-in-Preclinical-Study.html CLEVELAND, Nov. 19, 2015 (GLOBE NEWSWIRE) — Athersys, Inc. (Athersys) (NASDAQ:ATHX) announced today that multipotent adult progenitor cells (MAPC®), used in Athersys’ MultiStem® cell therapy currently in clinical development, are effective in improving the health of animals after acute rodent spinal cord injury. Intravenous administration of MAP…

http://www.cnn.com/2015/07/24/health/paralyzed-patients-stand-again/ By Elizabeth Cohen, Senior Medical Correspondent, and John Bonifield, CNN (CNN)In what’s being hailed as a breakthrough in spinal cord injury research, four men paralyzed from the chest down have risen from their wheelchairs on their own volition and effort. “I can stand up for more than half an hour,” said Dustin Shillcox, whoContinue reading “How paralyzed patients are able to stand against”

http://clinicaltrials.pharmaceutical-business-review.com/news/health-canada-grants-approval-for-stemcells-phase-ii-trial-for-cervical-spinal-cord-injury-190615-4604936 Health Canada has granted approval for StemCells to expand its Phase II clinical trial (Pathway Study) to evaluate the efficacy of company’s HuCNS-SC platform technology for chronic cervical spinal cord injury. The Phase II Pathway Study’s primary efficacy outcome is the change in motor strength of the…